1Jeffe E.S, Harris N.L, Stein H, et al. Pathology and Genetics of Tumours of haematopoitic and lymphoid tissues. World Health Organization Classification of Tumours[M].Lyon: IARC Press,2001.
2Ko YH, Ree HJ, Kim WS, et al. Clinicopathologic and genotypic study of extranodal nasal-type natural killer/T-cell lymphoma and natural killer precursor lymphoma among Koreans[J]. Cancer,2000,89:2106-2116.
3Filler A. C, Diebold J, Histopathology of nodal and extranodal non-Hodgkin' s lymphoma [M]. 3nd ed.Berlin: Springer Verlag, 2004.
4Harris N.L, Stem H, Coupland S.E, et al, New approaches to lymphoma diagnosis [J]. Hematology,2001, 194-262.
5Rubin E, Gorstein F, Rubin R, et al, Rubin's Pathology: Clinicopathologic Foundations of Medicine [M].4th edition. Lippincott: Williams & Wilkins, 2005.
6刘卫平,Joostvan Gorp,李甘地,刘永惠,李俸媛,万红,Roel A de Weger.中线恶网中的EB病毒感染[J].中华肿瘤杂志,1997,19(1):49-52. 被引量：27
7Takahashi N, Miura I,Chubachi A, et at. A clinicopathoiogica1 study of 20 patients with T/natural killer (NK)-cell lymphoma-associated hemophagocytic syndrome with special reference to nasal and nasal-type NK/T-cell lymphoma[J]. Int J Hematol, 2001,74(3):303.
8Drenou B, Lamy T, Amiot L, et al. CD3- CD56 + nonHodgkin's lyrnphomas with an aggressive behavior related to multidrug resistance[J]. Blood, 1997,89(8) : 2966.
9Jaffe ES, Krenacs L, Kumar DW, et al. Extranodal peripheral T-cell and NK-cell neoplasms[J]. Am J Clin Pathology, 1999,111(Suppl 1) :S45.
10Li YX,Coucke PA, Li JY, et al. Primary non-Hodgkin's lymphoma of the nasal cavity: prognostic significance of paranasal extension and the role of radiotherapy and chemotherapy[J]. Cancer, 1998,83:449.
